Compare IRS & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
Current Price
Current Price
| Metric | IRS | SDGR |
|---|---|---|
| Founded | 1943 | 1990 |
| Country | Argentina | United States |
| Employees | 1392 | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 925.8M |
| IPO Year | N/A | 2020 |
| Metric | IRS | SDGR |
|---|---|---|
| Price | $15.92 | $15.46 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $21.00 |
| AVG Volume (30 Days) | 166.7K | ★ 1.3M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 9.85% | N/A |
| EPS Growth | N/A | ★ 45.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $255,869,000.00 |
| Revenue This Year | N/A | $0.76 |
| Revenue Next Year | N/A | $4.60 |
| P/E Ratio | $3.66 | ★ N/A |
| Revenue Growth | N/A | ★ 23.29 |
| 52 Week Low | $10.87 | $10.95 |
| 52 Week High | $19.14 | $23.75 |
| Indicator | IRS | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 52.52 | 60.76 |
| Support Level | $15.81 | $11.27 |
| Resistance Level | $17.22 | $16.47 |
| Average True Range (ATR) | 0.76 | 0.91 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 41.60 | 61.67 |
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segments include Shopping Malls, which comprise lease and service revenues principally related to the rental of commercial and other spaces in the company's shopping malls; Offices, which include lease revenues and other service revenues related to office activities; Sales and Developments, which include the development, maintenance, and sales of undeveloped parcels of land and/or trading properties; Hotels, which mainly include revenues from rooms, catering, and restaurants; and others. The company generates the majority of its revenue from the Shopping Malls segment.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.